Ads
related to: penicillin dosage for gonorrhea pain medicine for women
Search results
Results From The WOW.Com Content Network
The antibiotic, which would be the first new gonorrhea treatment approved in decades, could make it to market by 2025. The World Health Organization estimates that globally there are more than 82 ...
Spectinomycin. Spectinomycin, sold under the tradename Trobicin among others, is an antibiotic useful for the treatment of gonorrhea infections. [2] It is given by injection into a muscle. [2] Common side effects include pain at the area of injection, rash, nausea, fever, and trouble sleeping. [2] Severe allergic reactions may occasionally ...
Gonorrhea. Gonorrhoea or gonorrhea, colloquially known as the clap, is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. [1] Infection may involve the genitals, mouth, or rectum. [7] Infected males may experience pain or burning with urination, discharge from the penis, or testicular pain. [1]
Antibiotic resistance in gonorrhea was first identified in the 1940s. Gonorrhea was treated with penicillin, but doses had to be progressively increased to remain effective. By the 1970s, penicillin-and tetracycline-resistant gonorrhea emerged in the Pacific Basin.
Also referred to as the doxy PEP regime, the CDC recommends that one 200-milligram dose of doxycycline be taken within 72 hours after oral, vaginal, or anal sex without a condom or other barrier ...
A study out of the University of York shows that carbon monoxide-releasing molecules could be the key to developing a new antibiotic to treat gonorrhea.
Neisseria gonorrhoeae, the bacterium that causes the sexually transmitted infection gonorrhea, has developed antibiotic resistance to many antibiotics. The bacteria was first identified in 1879. [1] In the 1940s effective treatment with penicillin became available, but by the 1970s resistant strains predominated.
Zoliflodacin. Zoliflodacin (development codes AZD0914 and ETX0914) is an experimental antibiotic that is being studied for the treatment of infection with Neisseria gonorrhoeae (gonorrhea). [1] It has a novel mechanism of action which involves inhibition of bacterial type II topoisomerases. [2]